Device Trials Focus of FDA Warning Letters

Clinical Trials Advisor
KEYWORDS FDA / Warning
A A

Last week the FDA posted three separate warning letters to its website citing a sponsor, an investigator and an IRB for a range of violations.

To View This Article:

Login

Subscribe To Clinical Trials Advisor

Buy This Article Now

Add this article to your cart for $10.00